Skip to main content
. 2022 Jan 22;62(4):1206–1213.e3. doi: 10.1016/j.japh.2022.01.015

Appendix 4.

Drug-related problems identified in chronic disease patients (N total = 427 DRPs) and univariate analysis in DRPs predict all of the other DRPs ( DRPs VS Non-DRPs )

Drug-related problems (DRPs) n (%) Odds ratio 95%CI P-value
1. Changes of drug packaging or drug brands 94 (18.84) 2.31 1.43-3.76 0.0002
2. Leftover medications more than 2 weeks 92 (18.44) 3.86 2.34-6.42 < 0.001
3. Non-adherence 87 (17.43) 2.39 1.46-3.95 0.0002
4. Having conditions or diseases requiring additional medications 34 (6.81) 0.83 0.69-1.01 0.058
5. Adverse drug reactions 26 (5.21) 3.61 1.41-10.33 0.0026
6. Having an emergency requiring treatment at a hospital before next appointment date 25 (5.01) 0.87 0.72- 1.04 0.142
7. Lack of knowledge about the purpose, administration and storage of drugs 23 (4.61) 0.88 0.73- 1.05 0.169
8. The quantity of drugs received is not sufficient to cover needs until next follow up 12 (2.40) 0.92 0.77- 1.10 0.389
9. Having abnormal symptoms due to a lack of drugs 8 (1.60) 0.94 0.78-1.12 0.499
10 The patient did not receive the drug. 7 (1.40) 0.94 0.79 - 1.12 0.528
11. Incorrect use of specialized drug administration devices or techniques (e.g. inhalers, injected medications) 6 (1.20) 0.94 0.79- 1.13 0.558
12. Experienced unexpected drug interactions with other drugs, food or supplements 5 (1.00) 0.95 0.79- 1.13 0.589
13. Patients do not understand the meaning of the printed materials included with drugs 4 (0.80) 0.95 0.81-1.14 0.621
14. Changes or errors in drug dosage (e.g. dispensing error, brand change/shortage) 4 (0.80) 0.95 0.80- 1.14 0.621